James Incalcaterra
Family Medicine · Houston, TXNPI 1609887082
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,276 and has fallen 91.1% since, to $203 in 2022.
Across 217 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$629
- Novo Nordisk$507
- AstraZeneca$287
- AbbVie$237
- Amgen$235
- Astellas Pharma US Inc$184
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,30897%
- Education$953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 41 | $629 |
| Novo Nordisk | 23 | $507 |
| AstraZeneca | 22 | $287 |
| AbbVie(2 entities) | 9 | $237 |
| Amgen | 15 | $235 |
| Astellas Pharma US Inc | 9 | $184 |
| Merck | 19 | $184 |
| Boehringer Ingelheim | 11 | $180 |
| Pfizer | 13 | $146 |
| GSK | 9 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $96 |
| Sanofi-aventis U.S. LLC | 5 | $69 |
| Arbor Pharmaceuticals, Inc. | 5 | $63 |
| Johnson & Johnson | 4 | $62 |
| Teva Pharmaceuticals USA, Inc. | 5 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $50 |
| Esperion Therapeutics, Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 3 | $42 |
| Genentech USA, Inc. | 2 | $40 |
| Shire North American Group Inc | 2 | $34 |
| Metuchen Pharmaceuticals | 2 | $26 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Eisai Inc. | 1 | $15 |
| Gilead | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,403 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Houston
- Shannon SchraderHouston$216K
- Candice WinfulHouston$173K
- Guljeet SohalHouston$72K
- Lakecia PittsHouston$71K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.